Pure Global

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) - Trial NCT03172494

Access comprehensive clinical trial information for NCT03172494 through Pure Global AI's free database. This Phase 3 trial is sponsored by Novo Nordisk A/S and is currently Completed. The study focuses on Diabetes,Diabetes Mellitus, Type 2. Target enrollment is 720 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT03172494
Phase 3
Completed
drug
Trial Details
ClinicalTrials.gov • NCT03172494
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

Study Focus

Insulin degludec/liraglutide

Interventional

drug

Sponsor & Location

Novo Nordisk A/S

Hefei,Beijing,Beijing,ChongQing,Fuzhou,Fuzhou,Guangzhou,Guangzhou,Guangzhou,Cangzhou,Shijiazhuang,Shijiazhuang,Changzhou,Huai'an,Huai'an,Nanjing,Nanjing,Nanjing,Zhenjiang,Nanchang,Changchun,Dalian,Yin, China

Timeline & Enrollment

Phase 3

May 26, 2017

Jul 13, 2019

720 participants

Primary Outcome

Change in HbA1c

Summary

This trial is conducted in Asia. The aim of this trial is to confirm the efficacy of insulin
 degludec/liraglutide in controlling glycaemia in Chinese subjects with type 2 diabetes
 mellitus inadequately controlled on oral antidiabetic agents

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT03172494

Non-Device Trial